GlassScriptPhysician profile
Rui Morimoto
NPI 1477121614
$1,560.14
in general payments reported to CMS, 2019-2025
15 companies · $1,285 in 2025
The $1,285 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $37.55 · 2022: $17.36 · 2024: $220 · 2025: $1,285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,505.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $276.20 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $240.97 | 2024-2025 | Evenity, Prolia, Prolia |
| Glaxosmithkline, LLC. | $228.25 | 2024-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $197.61 | 2024-2025 | Jardiance, Synjardy |
| Bayer Healthcare Pharmaceuticals INC. | $127.15 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $126.87 | 2024-2025 | Airsupra, Breztri |
| Lilly USA, LLC | $106.93 | 2025 | Zepbound, Mounjaro |
| Merck Sharp & Dohme LLC | $79.40 | 2025 | Capvaxive, Gardasil 9, M-M-R II |
| Abbott Laboratories | $52.89 | 2025 | Freestyle Libre 3 |
| Ars Pharmaceuticals Operations, INC. | $26.86 | 2025 | Neffy |
| Exact Sciences Corporation | $24.01 | 2025 | The Cologuard Plus Collection Kit |
| Abbvie INC. | $23.48 | 2025 | |
| Sun Pharmaceutical Industries INC. | $18.26 | 2021 | |
| Bausch & Lomb Americas INC. | $17.36 | 2022 | |
| Inspire Medical Systems, INC. | $13.90 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rui Morimoto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.